China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Internal Control Audit Report for the Year Ended December 31, 2025
| KPMG Huazhen LLP | KPMG Huazhen Certified Public Accountants | |||
|---|---|---|---|---|
| 8th Floor, KPMG Tower | (Special General Partnership | ) | ||
| Oriental Plaza | Beijing, China | |||
| 1 East Chang An Avenue | East Chang An Street | 1 | No. | |
| Beijing 100738 | KPMG Tower, Oriental Plaza | 8 Floor | ||
| China | Postal Code | :100738 | ||
| Telephone | +86 (10) 8508 5000 | Phone | +86 (10) 8508 5000 | |
| Fax | +86 (10) 8518 5111 | Fax | +86 (10) 8518 5111 | |
| Internet | kpmg.com/cn | Website | kpmg.com/cn |
Internal Control Audit Report
KPMG Huazhen Audit Document No. 2604667
To all shareholders of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.:
In accordance with the "Guidelines for Internal Control Audits" and relevant requirements of the Chinese Certified Public Accountant Professional Standards, we have audited the effectiveness of the internal control over the financial report of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (hereinafter referred to as "your company") as of December 31, 2025.
I. Responsibility of the Enterprise for Internal Control
According to the provisions of the "Basic Norms for Enterprise Internal Control," "Application Guidelines for Enterprise Internal Control," and "Evaluation Guidelines for Enterprise Internal Control," it is the responsibility of your company's board of directors to establish, improve, and effectively implement internal control and evaluate its effectiveness.